Cargando…
Prognostic value of performance status assessed by patients themselves, nurses, and oncologists in advanced non-small cell lung cancer
Accuracy in the assessment of performance status by oncologists has not been well evaluated. We investigated possible discrepancies in the assessment of performance status among patients, nurses, and oncologists, and evaluated the prognostic importance of each assessment. Two hundred and six inpatie...
Autores principales: | Ando, M, Ando, Y, Hasegawa, Y, Shimokata, K, Minami, H, Wakai, K, Ohno, Y, Sakai, S |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363970/ https://www.ncbi.nlm.nih.gov/pubmed/11742480 http://dx.doi.org/10.1054/bjoc.2001.2162 |
Ejemplares similares
-
Prognostic Factors for Short‐term Survival in Patients with Stage IV Non‐small Cell Lung Cancer
por: Ando, Masahiko, et al.
Publicado: (1999) -
Adjustment of creatinine clearance improves accuracy of Calvert's formula for carboplatin dosing.
por: Ando, Y., et al.
Publicado: (1997) -
Therapeutic Drug Monitoring of Etoposide in a 14‐Day Infusion for Non‐small‐cell Lung Cancer
por: Ando, Yuichi, et al.
Publicado: (1996) -
Therapeutic Drug Monitoring in 21‐Day Oral Etoposide Treatment for Lung Cancer
por: Ando, Yuichi, et al.
Publicado: (1996) -
Pharmacokinetic Study of Carboplatin Given on a 5‐Day Intravenous Schedule
por: Ando, Yuichi, et al.
Publicado: (1997)